€0.93
4.62%
Xetra, Sep 25, 09:02 am CEST. Market open.
ISIN
DE0006044001
Symbol
MAK
Index

MATERNUS-Kliniken Stock price

€0.98
+0.05 4.84% 1M
-1.03 51.25% 6M
-0.05 4.41% YTD
-0.13 11.36% 1Y
-2.23 69.53% 3Y
-4.38 81.78% 5Y
-0.35 26.42% 10Y
-0.53 35.00% 20Y
Xetra, Closing price Thu, Sep 24 2026
-0.43 30.36%
ISIN
DE0006044001
Symbol
MAK
Index

Is MATERNUS-Kliniken a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
€29.4m
Enterprise Value
€226.1m
Net debt
€196.8m
Cash
€8.5m
Shares outstanding
21.0m
Valuation (TTM | estimate)
P/E
negative
P/S
0.2 | -
EV/Sales
1.9 | -
EV/FCF
20.3
P/B
negative
Financial Health
Equity Ratio
-53.8%
Return on Equity
17.2%
ROCE
-8.8%
ROIC
-4.5%
Debt/Equity
-2.5
Financials (TTM | estimate)
Revenue
€118.0m | -
EBITDA
€3.9m
EBIT
€-4.9m
Net Income
€-13.9m
Free Cash Flow
€11.2m
Growth (TTM | estimate)
Revenue
3.5% | -
EBITDA
-62.2%
EBIT
-116.1%
Net Income
-5.2%
Free Cash Flow
-19.5%
Margin
Gross
88.0%
EBITDA
3.3%
EBIT
-4.2%
Net
-11.7%
Free Cash Flow
9.5%
More
EPS
€-0.7
FCF per Share
€0.5
Short interest
-
Employees
2k
Rev per Employee
€60.0k

MATERNUS-Kliniken Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a MATERNUS-Kliniken forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a MATERNUS-Kliniken forecast:

Hold
43%
Sell
57%

MATERNUS-Kliniken Events

Upcoming Event
SEP
30
Q2 2026 Earnings Call
in 5 days

Financial data from MATERNUS-Kliniken

Dec '25
+/-
%
118 118
4% 4%
100%
- Direct Costs 14 14
7% 7%
12%
104 104
5% 5%
88%
- Selling and Administrative Expenses 81 81
9% 9%
68%
- Research and Development Expense - -
-
-
3.88 3.88
62% 62%
3%
- Depreciation and Amortization 8.82 8.82
30% 30%
7%
EBIT (Operating Income) EBIT -4.94 -4.94
116% 116%
-4%
Net Profit -14 -14
5% 5%
-12%

In millions EUR.

Don't miss a Thing! We will send you all news about MATERNUS-Kliniken directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Maternus-Kliniken AG engages in the operation of senior housing facilities, nursing homes, and rehabilitation centers. It operates through the following segments: Rehabilitation, Senior Retirement Homes and Nursing Care Facilities, and Maternus AG. The Rehabilitation segment comprises follow-up treatment and rehabilitation measures in the indication areas orthopedics, behavioral orthopedics, cardiology, internal medicine, metabolic disorders, and neurology. The Senior Retirement Homes and Nursing Care Facilities segment specializes in full-station services care, short-term care, and assisted living. The Maternus AG segment provides primarily intersegmentary services. The company was founded in 1877 and is headquartered in Berlin, Germany.

Head office Germany
CEO Mario Ruano-Wohlers
Employees 1,869
Founded 1877
Website www.maternus.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today